Glenmark Pharmaceuticals

Results: 19



#Item
11Microsoft Word - Glenmark Q3FY12 Result Review.doc

Microsoft Word - Glenmark Q3FY12 Result Review.doc

Add to Reading List

Source URL: smartinvestor.business-standard.com

Language: English - Date: 2012-01-31 23:56:12
122QFY13 Result Update  Institutional Equities Glenmark Pharmaceuticals 31 October 2012

2QFY13 Result Update Institutional Equities Glenmark Pharmaceuticals 31 October 2012

Add to Reading List

Source URL: smartinvestor.business-standard.com

Language: English - Date: 2012-11-01 05:01:25
13GNP[removed]MOSL-RU-8PG.p65

GNP[removed]MOSL-RU-8PG.p65

Add to Reading List

Source URL: smartinvestor.business-standard.com

Language: English - Date: 2012-02-02 00:40:41
142QFY12 Result Update  Institutional Equities Glenmark Pharmaceuticals 11 November 2011

2QFY12 Result Update Institutional Equities Glenmark Pharmaceuticals 11 November 2011

Add to Reading List

Source URL: smartinvestor.business-standard.com

Language: English - Date: 2011-11-14 02:33:43
15Glenmark Pharmaceuticals Ltd. through its Swiss Subsidiary receives USD 4 Mn. as research fee payment from Forest Laboratories Inc. Total Payment received for the mpges-1 program from Forest Laboratories is USD 15 millio

Glenmark Pharmaceuticals Ltd. through its Swiss Subsidiary receives USD 4 Mn. as research fee payment from Forest Laboratories Inc. Total Payment received for the mpges-1 program from Forest Laboratories is USD 15 millio

Add to Reading List

Source URL: www.glenmarkpharma.com

Language: English - Date: 2014-03-25 01:20:03
16Glenmark Pharmaceuticals Ltd. through its Swiss Subsidiary receives USD 5 Mn. as milestone fee payment from Sanofi Total Payment received for GBR 500 monoclonal antibody programme from Sanofi is USD 55 Mn MUMBAI, April 1

Glenmark Pharmaceuticals Ltd. through its Swiss Subsidiary receives USD 5 Mn. as milestone fee payment from Sanofi Total Payment received for GBR 500 monoclonal antibody programme from Sanofi is USD 55 Mn MUMBAI, April 1

Add to Reading List

Source URL: www.glenmarkpharma.com

- Date: 2014-04-14 23:30:37
    17Microsoft Word - DESI 5 6 Q3 2007.RTF

    Microsoft Word - DESI 5 6 Q3 2007.RTF

    Add to Reading List

    Source URL: www.medicaid.ms.gov

    Language: English - Date: 2014-04-18 17:53:46
    18PAR Telmisar tan Glenmar k Gener ics/ Telmisar tan Glenmar k 20, 40 and 80mg Film-Coated Tablets UK/H[removed]DC UK/H[removed]DC

    PAR Telmisar tan Glenmar k Gener ics/ Telmisar tan Glenmar k 20, 40 and 80mg Film-Coated Tablets UK/H[removed]DC UK/H[removed]DC

    Add to Reading List

    Source URL: www.mhra.gov.uk

    Language: English - Date: 2014-06-26 10:10:02
    19From: Nilam Patel [mailto:[removed]] Sent: Monday, February 25, 2013 4:38 AM To: FUEHRING Stefan (SANCO) Subject: RE: Transporation of Active substance (our ref.: Ares[removed]Dear Stefan,

    From: Nilam Patel [mailto:[removed]] Sent: Monday, February 25, 2013 4:38 AM To: FUEHRING Stefan (SANCO) Subject: RE: Transporation of Active substance (our ref.: Ares[removed]Dear Stefan,

    Add to Reading List

    Source URL: ec.europa.eu

    Language: English - Date: 2013-11-07 08:55:18